Literature DB >> 20439706

Peptide antagonism as a mechanism for NK cell activation.

Lena Fadda1, Gwenoline Borhis, Parvin Ahmed, Kuldeep Cheent, Sophie V Pageon, Angelica Cazaly, Stavros Stathopoulos, Derek Middleton, Arend Mulder, Frans H J Claas, Tim Elliott, Daniel M Davis, Marco A Purbhoo, Salim I Khakoo.   

Abstract

Inhibition of natural killer (NK) cells is mediated by MHC class I receptors including the killer cell Ig-like receptor (KIR). We demonstrate that HLA-C binding peptides can function as altered peptide ligands for KIR and antagonize the inhibition mediated by KIR2DL2/KIR2DL3. Antagonistic peptides promote clustering of KIR at the interface of effector and target cells, but do not result in inhibition of NK cells. Our data show that, as for T cells, small changes in the peptide content of MHC class I can regulate NK cell activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439706      PMCID: PMC2890497          DOI: 10.1073/pnas.0913745107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand.

Authors:  J C Boyington; S A Motyka; P Schuck; A G Brooks; P D Sun
Journal:  Nature       Date:  2000-06-01       Impact factor: 49.962

Review 2.  Making sense of mass destruction: quantitating MHC class I antigen presentation.

Authors:  Jonathan W Yewdell; Eric Reits; Jacques Neefjes
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

Review 3.  MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen.

Authors:  Mario Lobigs; Arno Müllbacher; Matthias Regner
Journal:  Immunol Cell Biol       Date:  2003-06       Impact factor: 5.126

4.  Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.

Authors:  Andreas O Weinzierl; Despina Rudolf; Nina Hillen; Stefan Tenzer; Peter van Endert; Hansjörg Schild; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

5.  Specificity of peptide binding by the HLA-A2.1 molecule.

Authors:  N Shimojo; W L Maloy; R W Anderson; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

6.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

7.  Cutting edge: class I presentation of host peptides following HIV infection.

Authors:  Heather D Hickman; Angela D Luis; Wilfried Bardet; Rico Buchli; Casey L Battson; Michael H Shearer; Kenneth W Jackson; Ronald C Kennedy; William H Hildebrand
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

8.  Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

Authors:  Pokrath Hansasuta; Tao Dong; Hathairat Thananchai; Michael Weekes; Christian Willberg; Hatice Aldemir; Sarah Rowland-Jones; Veronique M Braud
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

9.  TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.

Authors:  Johannes B Huppa; Markus Axmann; Manuel A Mörtelmaier; Björn F Lillemeier; Evan W Newell; Mario Brameshuber; Lawrence O Klein; Gerhard J Schütz; Mark M Davis
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

10.  A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.

Authors:  Jakob Michaëlsson; Cristina Teixeira de Matos; Adnane Achour; Lewis L Lanier; Klas Kärre; Kalle Söderström
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more
  88 in total

Review 1.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Antagonizing inhibition gets NK cells going.

Authors:  Sumati Rajagopalan; Eric O Long
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-02       Impact factor: 11.205

Review 3.  Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.

Authors:  Peter Parham; Paul J Norman; Laurent Abi-Rached; Lisbeth A Guethlein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-03-19       Impact factor: 6.237

Review 4.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

Review 5.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

6.  KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys.

Authors:  Jamie L Schafer; Arnaud D Colantonio; William J Neidermyer; Dawn M Dudley; Michelle Connole; David H O'Connor; David T Evans
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

Review 7.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

8.  Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Authors:  Michael Rasmussen; Mikkel Harndahl; Anette Stryhn; Rachid Boucherma; Lise Lotte Nielsen; François A Lemonnier; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

9.  Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2+ HLA-C in Two Indigenous Human Populations in Southern Africa.

Authors:  Neda Nemat-Gorgani; Hugo G Hilton; Brenna M Henn; Meng Lin; Christopher R Gignoux; Justin W Myrick; Cedric J Werely; Julie M Granka; Marlo Möller; Eileen G Hoal; Makoto Yawata; Nobuyo Yawata; Lies Boelen; Becca Asquith; Peter Parham; Paul J Norman
Journal:  J Immunol       Date:  2018-03-16       Impact factor: 5.422

Review 10.  Structural insights into activation of antiviral NK cell responses.

Authors:  Kathryn A Finton; Roland K Strong
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.